Jedd D Wolchok


Ontology type: schema:Person     


Person Info

NAME

Jedd D

SURNAME

Wolchok

Publications in SciGraph latest 50 shown

  • 2019-04 Prognostic value of baseline metabolic tumor volume measured on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in melanoma patients treated with ipilimumab therapy in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2019-02 Correction to: Strategies for Predicting Response to Checkpoint Inhibitors in CURRENT HEMATOLOGIC MALIGNANCY REPORTS
  • 2019-01 Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2018-12 Acquired resistance to immunotherapy in MMR-D pancreatic cancer in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2018-10 Strategies for Predicting Response to Checkpoint Inhibitors in CURRENT HEMATOLOGIC MALIGNANCY REPORTS
  • 2018-03 Special Considerations in Immunotherapy Trials in ONCOLOGY CLINICAL TRIALS
  • 2017-12 Combination immunotherapy: a road map in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-12 Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-11 A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy in NATURE
  • 2017-07 Patient perspectives on ipilimumab across the melanoma treatment trajectory in SUPPORTIVE CARE IN CANCER
  • 2017-05 Chromatin states define tumour-specific T cell dysfunction and reprogramming in NATURE
  • 2017-05 T-cell invigoration to tumour burden ratio associated with anti-PD-1 response in NATURE
  • 2017-04 Inside the USCAP Journals in MODERN PATHOLOGY
  • 2017-04 Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology–molecular associations: clinical and biological implications in MODERN PATHOLOGY
  • 2017-04 Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies in NATURE REVIEWS ENDOCRINOLOGY
  • 2017-02-13 Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity in NATURE COMMUNICATIONS
  • 2017 Validation of Anti-Mouse PDL-1 Goat Polyclonal Antibody Staining with Mouse PDL-1 In Situ Hybridization on Adjacent Sections of Cell Pellets and Mouse Tumors in SIGNAL TRANSDUCTION IMMUNOHISTOCHEMISTRY
  • 2017 Glucocorticoid-Induced TNF Receptor (GITR) in CANCER THERAPEUTIC TARGETS
  • 2016-12 Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-12 Corrigendum: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET in NATURE MEDICINE
  • 2016-11 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-11 Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells in NATURE
  • 2016-07 Melanoma and immunotherapy bridge 2015 in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2016-06 The future of cancer treatment: immunomodulation, CARs and combination immunotherapy in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2016-05 The future of cancer treatment: immunomodulation, CARs and combination immunotherapy in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2016-02-02 Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis in NATURE COMMUNICATIONS
  • 2015-12 The PTEN pathway in Tregs functions as a critical driver of the immunosuppressive tumor microenvironment and tolerance to apoptotic cells in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI) in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation in NATURE COMMUNICATIONS
  • 2015-12 Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Direct comparisons of T cell costimulation and checkpoint blockade in the setting of tumor-targeted monoclonal antibody therapy in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-02 Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25 in CELL RESEARCH
  • 2015-01 Ipilimumab and whole brain radiation therapy for melanoma brain metastases in JOURNAL OF NEURO-ONCOLOGY
  • 2014-12 Potentiation of immunomodulatory antibodies with oncolytic viruses for therapy of poorly-immunogenic tumors in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Immune modulation for cancer therapy in BRITISH JOURNAL OF CANCER
  • 2014-12 Ipilimumab in patients with melanoma and autoimmune disease in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC) in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Opportunistic infections in patients treated with immunotherapy for cancer in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Impairment of Treg suppression by GITR ligation is effective selectively in the context of a pro-inflammatory tumor microenvironment in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Blockade of surface bound TGF-β abrogates Treg suppression of effector T cell function within the tumor microenvironment in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Expression of indoleamine 2.3-dioxygenase by tumors induces local and systemic immunosuppressive effects in a murine melanoma model in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi) in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Patterns of long-term survival following Ipilimumab (Ipi): the Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-11 Cancer: Antitumour immunity gets a boost in NATURE
  • 2014-05 Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2014-04-15 Cancer's Off Switch in SCIENTIFIC AMERICAN
  • 2014 Markers for Anti-cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Therapy in Melanoma in MOLECULAR DIAGNOSTICS FOR MELANOMA
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.51462.34", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410718.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240614.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413575.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.47100.32", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416477.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.489192.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5386.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240324.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.266102.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21729.3f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.270240.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.453260.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.224260.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.1052.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.25879.31", 
            "type": "Organization"
          }
        ], 
        "familyName": "Wolchok", 
        "givenName": "Jedd D", 
        "id": "sg:person.0645565266.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645565266.33"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:42", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_456.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0645565266.33'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0645565266.33'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0645565266.33'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0645565266.33'


     

    This table displays all metadata directly associated to this object as RDF triples.

    48 TRIPLES      10 PREDICATES      27 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0645565266.33 schema:affiliation Nb68a8552e25846199f28167697097d67
    2 https://www.grid.ac/institutes/grid.1052.6
    3 https://www.grid.ac/institutes/grid.21729.3f
    4 https://www.grid.ac/institutes/grid.224260.0
    5 https://www.grid.ac/institutes/grid.240145.6
    6 https://www.grid.ac/institutes/grid.240324.3
    7 https://www.grid.ac/institutes/grid.240614.5
    8 https://www.grid.ac/institutes/grid.25879.31
    9 https://www.grid.ac/institutes/grid.266102.1
    10 https://www.grid.ac/institutes/grid.270240.3
    11 https://www.grid.ac/institutes/grid.410718.b
    12 https://www.grid.ac/institutes/grid.413575.1
    13 https://www.grid.ac/institutes/grid.416477.7
    14 https://www.grid.ac/institutes/grid.453260.6
    15 https://www.grid.ac/institutes/grid.47100.32
    16 https://www.grid.ac/institutes/grid.489192.f
    17 https://www.grid.ac/institutes/grid.5386.8
    18 schema:familyName Wolchok
    19 schema:givenName Jedd D
    20 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645565266.33
    21 schema:sdDatePublished 2019-03-07T14:42
    22 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    23 schema:sdPublisher N1fdfca0f3ad84a9b812d3fd430d56baa
    24 sgo:license sg:explorer/license/
    25 sgo:sdDataset persons
    26 rdf:type schema:Person
    27 N1fdfca0f3ad84a9b812d3fd430d56baa schema:name Springer Nature - SN SciGraph project
    28 rdf:type schema:Organization
    29 Nb68a8552e25846199f28167697097d67 schema:affiliation https://www.grid.ac/institutes/grid.51462.34
    30 sgo:isCurrent true
    31 rdf:type schema:OrganizationRole
    32 https://www.grid.ac/institutes/grid.1052.6 schema:Organization
    33 https://www.grid.ac/institutes/grid.21729.3f schema:Organization
    34 https://www.grid.ac/institutes/grid.224260.0 schema:Organization
    35 https://www.grid.ac/institutes/grid.240145.6 schema:Organization
    36 https://www.grid.ac/institutes/grid.240324.3 schema:Organization
    37 https://www.grid.ac/institutes/grid.240614.5 schema:Organization
    38 https://www.grid.ac/institutes/grid.25879.31 schema:Organization
    39 https://www.grid.ac/institutes/grid.266102.1 schema:Organization
    40 https://www.grid.ac/institutes/grid.270240.3 schema:Organization
    41 https://www.grid.ac/institutes/grid.410718.b schema:Organization
    42 https://www.grid.ac/institutes/grid.413575.1 schema:Organization
    43 https://www.grid.ac/institutes/grid.416477.7 schema:Organization
    44 https://www.grid.ac/institutes/grid.453260.6 schema:Organization
    45 https://www.grid.ac/institutes/grid.47100.32 schema:Organization
    46 https://www.grid.ac/institutes/grid.489192.f schema:Organization
    47 https://www.grid.ac/institutes/grid.51462.34 schema:Organization
    48 https://www.grid.ac/institutes/grid.5386.8 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...